World Vitiligo Day, occurring annually on June 25th, is established in honor of the late pop music legend Michael Jackson, whose public image transformations sparked extensive discussions, yet he privately battled with severe vitiligo. The misconceptions surrounding his condition prompted the establishment of this commemorative day to enhance global awareness, understanding, and attention towards vitiligo, a skin disorder.
Vitiligo is a common pigmentary disorder characterized by the appearance of localized or widespread white patches on the skin and/or hair, resulting from damage or loss of melanocytes, cells responsible for producing melanin, the pigment that imparts color to skin, eyes, and hair. It affects people of all ethnicities, with similar prevalence rates between males and females; although it can onset at any age, it is more frequently observed during adolescence.
The exact mechanisms triggering vitiligo remain elusive, but current research implicates a multifaceted interplay involving genetics, autoimmune responses, oxidative stress, and neural factors in its development.
In recent years, significant breakthroughs in vitiligo research have been achieved globally. For instance, preliminary studies revealed a notably reduced activity of the Nrf2 signaling pathway in vitiligo patients, rendering melanocytes more vulnerable to damage. Nrf2, a key regulator in combating oxidative stress, safeguards against melanocyte apoptosis induced by hydrogen peroxide. Consequently, activating the Nrf2 pathway has emerged as a vital therapeutic strategy.
Ongoing explorations into therapeutic targets for vitiligo have expanded beyond JAK inhibitors. Researchers have uncovered a direct toxic effect of IFN-γ on melanocytes in vitiligo-affected skin, suggesting potential therapeutic value for human anti-IFN-γ monoclonal antibodies. Additionally, a Chinese research team has found that inhibiting MIF improves disease progression in vitiligo mouse models, indicating a promising new target for vitiligo treatment.
CUSABIO consistently dedicates itself to providing high-quality research reagents such as proteins, antibodies, and ELISA kits to researchers. Given the criticality and urgency of vitiligo research, we have specially curated a list of more than 20 popular targets and related reagent products pertinent to vitiligo studies below for your selection.
Product Name | Code | Target | Detection Range | Sensitivity |
---|---|---|---|---|
Rat Catalase (CAT) ELISA kit | CSB-E13439r | CAT | 93.75 mIU/mL-6000 mIU/mL | 23.43 mIU/mL |
Human Catalase (CAT) ELISA kit | CSB-E13635h | CAT | 15.6 pg/mL-1000 pg/mL | 3.9 pg/mL |
Mouse Catalase (CAT) ELISA Kit | CSB-E14190m | CAT | 15.6 pg/mL-1000 pg/mL | 3.9 pg/mL |
Fish Catalase (CAT) ELISA kit | CSB-E15928Fh | CAT | 125 mU/mL-2000 mU/mL | 62.5 mU/mL |
Human cluster of differentiation 4,CD4 ELISA Kit | CSB-E08956h | CD4 | 0.625 ng/mL-40 ng/mL | 0.156 ng/mL |
Rat cluster of differentiation 4,CD4 ELISA Kit | CSB-E12928r | CD4 | 0.78 U/mL-50 U/mL | 0.195 U/mL |
Chicken Cluster of Differentiation 4(CD4) ELISA Kit | CSB-E13114C | CD4 | 3.125 ng/mL-800 ng/mL | 3.125 ng/mL |
Human Cluster of differentiation 8,CD8 ELISA Kit | CSB-E12707h | CD8A | 62.5 U/mL-4000 U/mL | 15.6 U/mL |
Human cytotoxic T lymphocyte associated antigen 4,CTLA-4 ELISA Kit | CSB-E09171h | CTLA4 | 125 pg/mL-8000 pg/mL | 31.25 pg/mL |
Mouse cytotoxic T lymphocyte associated antigen 4,CTLA-4 ELISA Kit | CSB-E13637m | CTLA4 | 0.312 ng/mL-20 ng/mL | 0.078 ng/mL |
Human interferon-inducible protein 10,IP-10 ELISA Kit | CSB-E08181h | CXCL10 | 31.25 pg/mL-2000 pg/mL | 7.8 pg/mL |
Rat interferon-inducible protein 10,IP-10 ELISA Kit | CSB-E08182r | CXCL10 | 781.25 pg/mL-50000 pg/mL | 195 pg/mL |
Mouse interferon-inducible protein 10,IP-10 ELISA Kit | CSB-E08183m | CXCL10 | 0.312 ng/ml - 20 ng/ml | 0.078 ng/ml |
Monkey C-X-C motif chemokine 10(CXCL10) ELISA kit | CSB-EL006240RH | CXCL10 | 62.5 pg/mL-4000 pg/mL | 15.6 pg/mL |
Human Interleukin 8,IL-8 ELISA KIT | CSB-E04641h | CXCL8 | 31.25 pg/mL-2000 pg/mL | 7.110 pg/mL |
Pig interleukin 8,IL-8 ELISA Kit | CSB-E06787p | CXCL8 | 125 pg/mL-8000 pg/mL | 31.25 pg/mL |
Dog Interleukin-8,IL-8 ELISA Kit | CSB-E08052c | CXCL8 | 0.312 ng/mL-20 ng/mL | 0.146 ng/mL |
Rabbit Interleukin 8,IL-8 ELISA Kit | CSB-E06905Rb | CXCL8 | 23.5 pg/mL-1500 pg/mL | 5.8 pg/mL |
Monkey Interleukin-8,IL-8 ELISA Kit | CSB-E08051Mo | CXCL8 | 31.25 pg/mL-2000 pg/mL | 7.81 pg/mL |
Bovine Interleukin 8,IL-8 ELISA Kit | CSB-E13052B | CXCL8 | 50 pg/mL-2000 pg/mL | 50 pg/mL |
Product Name | Code | Target | Source | Tag Info |
---|---|---|---|---|
Recombinant Macaca mulatta Interleukin-10 (IL10) | CSB-BP011580MOW | IL10 | Baculovirus | N-terminal 10xHis-tagged and C-terminal myc-tagged |
Recombinant Macaca mulatta Interleukin-10 (IL10) | CSB-BP011580MOWd7 | IL10 | Baculovirus | C-terminal 10xHis-tagged |
Recombinant Human Macrophage migration inhibitory factor (MIF) | CSB-BP013826HU | MIF | Baculovirus | N-terminal 10xHis-tagged and C-terminal Myc-tagged |
Recombinant Rat Transforming growth factor beta-1 proprotein (Tgfb1), partial | CSB-BP023446RA | Tgfb1 | Baculovirus | N-terminal 6xHis-tagged |
Recombinant Marmota monax Tumor necrosis factor (TNF), partial | CSB-BP523593MQG | TNF | Baculovirus | N-terminal 10xHis-tagged |
Recombinant Human T-cell surface glycoprotein CD4 (CD4), partial | CSB-CF004935HU1 | CD4 | in vitro E.coli expression system | N-terminal 6xHis-tagged |
Recombinant Human C-X-C chemokine receptor type 3 (CXCR3) | CSB-CF006253HU | CXCR3 | in vitro E.coli expression system | N-terminal 6xHis-tagged |
Recombinant Human C-X-C chemokine receptor type 3 (CXCR3) | CSB-CF006253HUb0 | CXCR3 | in vitro E.coli expression system | N-terminal 10xHis-tagged |
Recombinant Mouse Catalase (Cat) | CSB-EP004563MO | Cat | E.coli | N-terminal 10xHis-tagged and C-terminal myc-tagged |
Recombinant Bovine T-cell surface glycoprotein CD8 alpha chain (CD8A), partial | CSB-EP004966BO | CD8A | E.coli | N-terminal 6xHis-SUMO-tagged |
Recombinant Human T-cell surface glycoprotein CD8 alpha chain (CD8A), partial | CSB-EP004966HU | CD8A | E.coli | N-terminal 6xHis-SUMO-tagged |
Recombinant Human Cytotoxic T-lymphocyte protein 4 (CTLA4), partial | CSB-EP006163HU1 | CTLA4 | E.coli | N-terminal 6xHis-tagged |
Recombinant Mouse Cytotoxic T-lymphocyte protein 4 (Ctla4), partial | CSB-EP006163MO1 | Ctla4 | E.coli | N-terminal 10xHis-SUMO-tagged and C-terminal Myc-tagged |
Recombinant Human C-X-C motif chemokine 10 (CXCL10) | CSB-EP006240HU | CXCL10 | E.coli | N-terminal 6xHis-tagged |
Recombinant Human C-X-C motif chemokine 10 (CXCL10) | CSB-EP006240HUc7 | CXCL10 | E.coli | C-terminal 6xHis-tagged |
Recombinant Mouse C-X-C motif chemokine 10 (Cxcl10) | CSB-EP006240MO | Cxcl10 | E.coli | N-terminal GST-tagged |
Recombinant Human C-X-C motif chemokine 9 (Cxcl9) | CSB-EP006252HU | CXCL9 | E.coli | N-terminal 10xHis-tagged and C-terminal Myc-tagged |
Recombinant Mouse C-X-C motif chemokine 9 (Cxcl9) | CSB-EP006252MO | Cxcl9 | E.coli | N-terminal 6xHis-tagged |
Recombinant Rabbit C-X-C motif chemokine (CXCL9) | CSB-EP006252RB | CXCL9 | E.coli | N-terminal 6xHis-SUMO-tagged |
Recombinant Human C-X-C chemokine receptor type 3 (CXCR3), partial | CSB-EP006253HU1 | CXCR3 | E.coli | N-terminal 6xHis-GST-tagged |
Product Name | Code | Target | Species Reactivity | Tested Applications |
---|---|---|---|---|
CD4 Recombinant Monoclonal Antibody | CSB-RA004935A0HU | CD4 | Human | ELISA, WB, IHC |
CD8A Recombinant Monoclonal Antibody | CSB-RA934881A0HU | CD8A | Human | ELISA, WB, IHC, IP |
CTLA4 Recombinant Monoclonal Antibody | CSB-RA213310A0HU | CTLA4 | Human | ELISA, IHC |
CTLA4 Recombinant Monoclonal Antibody | CSB-RA006163MA1HU | CTLA4 | Human, Mouse | ELISA, WB, IF, FC |
CXCL10 Recombinant Monoclonal Antibody | CSB-RA903061A0HU | CXCL10 | Human | ELISA, IHC |
IL10 Recombinant Monoclonal Antibody | CSB-RA011580A0HU | IL10 | Human | ELISA |
IL17A Recombinant Monoclonal Antibody | CSB-RA624104MA1HU | IL17A | Human | ELISA |
IL6 Recombinant Monoclonal Antibody | CSB-RA011664MA1HU | IL6 | Human | ELISA |
JAK1 Recombinant Monoclonal Antibody | CSB-RA227790A0HU | JAK1 | Human | ELISA, IHC |
Phospho-JAK2 (Y1007 + Y1008) Recombinant Monoclonal Antibody | CSB-RA011931A100phHU | JAK2 | Human | ELISA, WB, IHC, IP |
JAK2 Recombinant Monoclonal Antibody | CSB-RA267127A0HU | JAK2 | Human | ELISA, IF |
JAK3 Recombinant Monoclonal Antibody | CSB-RA206737A0HU | JAK3 | Human | ELISA, IHC |
MIF Recombinant Monoclonal Antibody | CSB-RA146975A0HU | MIF | Human | ELISA, WB |
PDCD1 Recombinant Monoclonal Antibody | CSB-RA240597A0HU | PDCD1 | Human | ELISA, WB, IHC |
TYR Recombinant Monoclonal Antibody | CSB-RA567167A0HU | TYR | Human | ELISA, IF |
Product Name | Code | Target | Species Reactivity | Tested Applications |
---|---|---|---|---|
CD4 Monoclonal Antibody | CSB-MA000228 | CD4 | Human,Mouse,Rat | ELISA, IHC |
CD4 Monoclonal Antibody,Purified | CSB-MA783233 | CD4 | Human | ELISA, FC |
CD8A Monoclonal Antibody,Purified | CSB-MA927984 | CD8A | Human | ELISA, FC |
CTLA4 Monoclonal Antibody | CSB-MA006163A0m | CTLA4 | Human | ELISA, WB, IHC |
CXCL8 Monoclonal Antibody | CSB-MA083271A0m | CXCL8 | Human | ELISA, IHC |
IFNG Monoclonal Antibody | CSB-MA065241A0m | IFNG | Human | ELISA, IHC |
IL1B Monoclonal Antibody | CSB-MA065741A0m | IL1B | Human | ELISA |
IL1B Monoclonal Antibody | CSB-MA010884 | IL1B | Human | ELISA, WB, IHC, ICC |
IL6 Monoclonal Antibody | CSB-MA067571A0m | IL6 | Human | ELISA, WB, IHC |
JAK1 Monoclonal Antibody | CSB-MA919964 | JAK1 | Human,Mouse,Rat | ELISA, IHC |
JAK2 Monoclonal Antibody | CSB-MA181103 | JAK2 | Human,Mouse,Rat | ELISA, IHC |
JAK2 Monoclonal Antibody | CSB-MA780030 | JAK2 | Human,Mouse,Rat | ELISA, IHC |
TNF Monoclonal Antibody | CSB-MA084771A0m | TNF | Bovine | ELISA |
TNF Monoclonal Antibody | CSB-MA080271 | TNF | Human,Mouse,Rat | ELISA, WB, IHC |
TNF Monoclonal Antibody | CSB-MA080272 | TNF | Human,Mouse,Rat | ELISA, WB, IHC |
Product Name | Code | Target | Species Reactivity | Tested Applications |
---|---|---|---|---|
CAT Antibody | CSB-PA004980 | CAT | Human | ELISA, WB |
Phospho-CAT (Y386) Antibody | CSB-PA070042 | CAT | Human, Mouse, Rat | ELISA, WB, IHC |
CAT Antibody | CSB-PA070043 | CAT | Human, Mouse, Rat | ELISA, IHC |
CAT Antibody | CSB-PA004563GA01HU | CAT | Human, Mouse, Rat | ELISA, WB, IHC |
CAT Antibody | CSB-PA599838 | CAT | Human, Mouse, Rat | ELISA, WB, IHC |
CAT Antibody | CSB-PA942303 | CAT | Human, Mouse, Rat | ELISA, WB, IHC |
CD4 Antibody | CSB-PA004935ESR2HU | CD4 | Human | ELISA, IHC |
Phospho-CD4 (S433) Antibody | CSB-PA070257 | CD4 | Human, Mouse | ELISA, IHC, IF |
CD4 Antibody | CSB-PA001453 | CD4 | Human, Mouse | ELISA, WB, IHC, IF |
CD4 Antibody | CSB-PA004935GA01HU | CD4 | Human, Mouse, Rat | ELISA, WB |
CD8A Antibody | CSB-PA004966LA01HU | CD8A | Human | ELISA, IHC |
CTLA4 Antibody | CSB-PA006163LA01HU | CTLA4 | Human | ELISA, IF |
CTLA4 Antibody | CSB-PA252417 | CTLA4 | Human | ELISA, IHC |
CTLA4 Antibody | CSB-PA006163KA01HU | CTLA4 | Human | ELISA, WB, IHC |
CTLA4 Antibody | CSB-PA224600 | CTLA4 | Human, Mouse, Rat | ELISA, IHC |
CXCL10 Antibody | CSB-PA06107A0Rb | CXCL10 | Human | ELISA |
CXCL10 Antibody | CSB-PA822646LA01MOW | CXCL10 | Macaca mulatta | ELISA |
CXCL10 Antibody | CSB-PA761371 | CXCL10 | Human | ELISA, IHC |
CXCL8 Antibody | CSB-PA011671YA01DO | CXCL8 | Dog | ELISA |
CXCL8 Antibody | CSB-PA08327A0Rb | CXCL8 | Human | ELISA, WB, IHC |